Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New strategy for treating cancer

05.09.2011
Using a strategy based on treating cancer cells that carry a specific genetic signature – hyper-expression of the protein Myc – with therapy that affects the stability of the cell’s DNA, more effective results can be achieved. This was discovered by Andreas Höglund in his dissertation to be publicly defended at Umeå University on September 9.

Today cancer is a public health disease that statistically afflicts every third Swede some time during their lifetimes. Although certain external factors such as smoking, obesity, and exaggerated sunbathing increase the risk of cancer, everyone can develop this disease, regardless of these factors.

This is because during our lifetime we gather mutations in our genes that govern how the body’s cells grow and multiply. Sometimes these mutations affect important cellular programs, entailing that a cell somewhere in the body receives a growth advantage that makes it grow and multiply until a tumor has been formed.

In his dissertation, Andreas Höglund shows that cancer cells that carry a specific genetic defect are extra susceptible to treatment that damages the cells’ DNA.

“Cancer cells that express the protein Myc at unnaturally high levels are extra sensitive to these types of treatment,” says Andreas Höglund.

Myc is a vital protein in the body that governs the reading of thousands of genes. Myc does not cause cancer until mutations lead to abnormally high levels of this protein, and further defense mechanisms are knocked out. Defective expression of Myc is one of the most common causes of cancer.

In the dissertation studies Andreas Höglund also maps signalling paths that govern the cell’s ability to recognize and repair damaged DNA. In collaboration with pharmacuetical companies, small chemical compounds have been tested in the hope of being able to develop these beyond a preclinical setting. By steering the binding of these compounds to precisely those signal paths that govern the cell’s ability to recognize and repair DNA damage, it was possible to neutralize the cancer cells.

“Directing treatment toward the signal paths we have identified is highly appropriate for cancer cells with high Myc levels. The hope is to be able to use the Myc signature in a number of cancer diseases in order to attain more specific treatment, which also has the potential of reducing side effects in comparison with current treatment methods,” says Andreas Höglund.

Andreas Höglund was born and raised in Härnösand, where he majored in science in high school, graduating in 1999. In 2001 he started the master’s program in biotechnology at Umeå University, finishing in 2006.

About the public defense
On Friday, September 9, Andreas Höglund, Department of Molecular Biology, Umeå University, will publicly defend his dissertation titled: Regulation of DNA damage responses by the MYC oncogene – Implications for future anti-cancer therapies.

The external examiner is Professor Thomas Helleday, Department of Genetics, Microbiology, and Toxicology, Stockholm University, Stockholm, Sweden and Gray Institute for Radiation and Biology, Oxford University, UK.

For further information, please contact:
Andreas Höglund, Department of Molecular Biology
Mobile phone: +46 (0)70-264 44 94
E-mail: andreas.hoglund@molbiol.umu.se

Ingrid Söderbergh | idw
Further information:
http://www.vr.se
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-44284

More articles from Health and Medicine:

nachricht Team discovers how bacteria exploit a chink in the body's armor
20.01.2017 | University of Illinois at Urbana-Champaign

nachricht Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Helmholtz International Fellow Award for Sarah Amalia Teichmann

20.01.2017 | Awards Funding

An innovative high-performance material: biofibers made from green lacewing silk

20.01.2017 | Materials Sciences

Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery

20.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>